# Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)

> **NCT02591901** · PHASE2 · COMPLETED · sponsor: **Buckinghamshire Healthcare NHS Trust** · enrollment: 48 (actual)

## Conditions studied

- UTI
- Neurogenic Bladder
- Antibiotic Resistance

## Interventions

- **DRUG:** Uro vaxom
- **OTHER:** Placebo comparator

## Key facts

- **NCT ID:** NCT02591901
- **Lead sponsor:** Buckinghamshire Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-06
- **Primary completion:** 2019-08-02
- **Final completion:** 2019-09-21
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02591901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02591901, "Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02591901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*